Is Harmony Biosciences Holdings, Inc. (HRMY) a Buy, Sell, or Hold?
NASDAQ : HRMY
Harmony Biosciences Holdings, Inc. — Analyst Ratings
$34.73 USD
-$1.13 (-3.15%)
- Volume
- 202.49K
- Average Volume
- 830.89K
- Market Capitalization
- $2.01B
- P/E Ratio
- 13.78
- Dividend Yield
- 0.00%
- Price Target
- $46.00
- Year High
- $40.87
- Year Low
- $25.52
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.58
Analyst Consensus Summary
Consensus Rating
Buy
13 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
-24.5%
vs Current Price
Price Target
$46.00
Average TargetPrice Target Range
Lowest Target
$36.00
-3.5% DOWNSIDE
Average Target
$46.00
Median Estimate
Highest Target
$50.00
-30.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 3 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Deutsche Bank | David Hoang | $36 | $36.22 | 2026-06-30 09:35 AM | -0.6% |
| UBS | Youn Shim | $46 | $37.93 | 2026-02-11 07:28 AM | 21.3% |
| Oppenheimer | Andreas Argyrides | $62 | $34.31 | 2025-11-24 04:40 AM | 80.7% |